Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion

Novartis said it would buy cancer-drug maker Endocyte for $2.1 billion, the Swiss pharmaceutical giant’s latest move to refocus on higher-value medicines.

from WSJ.com: US Business https://ift.tt/2AhqDtT
via IFTTT